French president Nicolas Sarkozy has given approval for an increased role for the country's mutual insurance companies in the coverage of chronic diseases.
Pres Sarkozy said the public-sector health fund system could not fund everything and added that he would legislate if current negotiations on medical treatment cost overshoots did not conclude satisfactorily and soon. He suggested that initially pilot projects could be launched on a joint basis by the government and the mutual sector to see if the quality and efficiency of chronic disease reimbursement could be improved.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze